We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
CIS
676
Connors Investor Services
Pennsylvania
$6.89M +$521K +16,574 +8%
SBWIC
677
Schaper Benz & Wise Investment Counsel
Wisconsin
$6.88M +$38.1K +1,212 +0.5%
PWM
678
Patriot Wealth Management
Texas
$6.8M -$11.5K -365 -0.2%
SCM
679
Salem Capital Management
Massachusetts
$6.8M +$31.5K +1,001 +0.5%
FFH
680
Fairfax Financial Holdings
Ontario, Canada
$6.78M -$829K -26,350 -11%
FA
681
FDx Advisors
Illinois
$6.76M +$609K +19,371 +10%
NRS
682
Neville Rodie & Shaw
New York
$6.75M +$753K +23,935 +12%
TCM
683
Tran Capital Management
California
$6.7M -$70.5K -2,240 -1%
MI
684
Markston International
New York
$6.64M +$16.6K +527 +0.2%
EWM
685
Endurance Wealth Management
Rhode Island
$6.64M -$145K -4,622 -2%
SCI
686
SkyBridge Capital II
New York
$6.62M +$6.8M +216,242 New
CIA
687
Choate Investment Advisors
Massachusetts
$6.61M +$877K +27,867 +14%
AIP
688
Ameritas Investment Partners
Nebraska
$6.6M +$49K +1,559 +0.7%
NCM
689
Novare Capital Management
North Carolina
$6.59M +$52.7K +1,676 +0.8%
JC
690
Jacobs & Co
California
$6.54M -$2.23K -71 -0%
SGA
691
Strategic Global Advisors
California
$6.54M +$1.67M +53,213 +33%
CVM
692
Cheviot Value Management
California
$6.53M -$18.7K -595 -0.3%
SGAM
693
Steinberg Global Asset Management
Florida
$6.53M +$187K +5,950 +3%
DY
694
Dowling & Yahnke
California
$6.49M -$99.8K -3,171 -1%
WPC
695
Waters Parkerson & Co
Louisiana
$6.48M +$20.6K +654 +0.3%
CPA
696
Cowen Prime Advisors
New York
$6.45M -$259K -8,222 -4%
CFSG
697
Community Financial Services Group
Vermont
$6.45M +$10.3K +329 +0.2%
HCM
698
Hollencrest Capital Management
California
$6.39M +$7.8K +248 +0.1%
BCM
699
Birmingham Capital Management
Alabama
$6.39M +$36.4K +1,156 +0.6%
RW
700
Rand Wealth
Maryland
$6.38M -$179K -5,687 -3%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.